Literature DB >> 7593776

Treatment of adenoma sebaceum with the copper vapor laser.

A J Kaufman1, R C Grekin, J K Geisse, I J Frieden.   

Abstract

BACKGROUND: Angiofibromas of the central part of the face (adenoma sebaceum) occur pathognomonically in tuberous sclerosis, causing significant cosmetic and hygienic morbidity. Treatment has included excision, dermabrasion, cryosurgery, carbon dioxide laser, and argon laser. Copper vapor lasers emit light at 511 nm (green) ad 578 nm (yellow), useful for treating pigmented and vascular lesions, respectively.
OBJECTIVE: Because of the vascular nature and progressive pigmentation of adenoma sebaceum, we examined the utility of the copper vapor laser in treating this disorder.
METHODS: Nine patients with adenoma sebaceum were treated with the copper vapor laser. Individual lesions were treated with the yellow light (578 nm) at 0.4 to 0.6 mW. Pigmented lesions or lesions resistant to treatment were treated with the green light (511 nm) at 0.4 to 0.9 mW. Intervals between treatments were at least 6 weeks.
RESULTS: Good to excellent cosmetic results were seen in all treated patients. Scarring or hyperpigmentation occurred in none of the patients. Most patients required additional treatments with the copper vapor laser as new lesions developed.
CONCLUSION: The copper vapor laser is safe and effective for the treatment of adenoma sebaceum in tuberous slerosis.

Entities:  

Mesh:

Year:  1995        PMID: 7593776     DOI: 10.1016/0190-9622(95)91814-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  A young lady with abdominal pain and facial lesions.

Authors:  M E Bhaskar; B Kumar
Journal:  Indian J Nephrol       Date:  2010-07

2.  [Laser skin resurfacing and fibrin sealing as successful treatment for facial angiofibromas in tuberous sclerosis].

Authors:  A Pantelis; F Bootz; T Kühnel
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

3.  Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin.

Authors:  Mary Kay Koenig; Adelaide A Hebert; Joan Roberson; Joshua Samuels; John Slopis; Audrey Woerner; Hope Northrup
Journal:  Drugs R D       Date:  2012-09-01

4.  Rhinophyma in tuberous sclerosis complex: case report with brief review of literature.

Authors:  Reinhard E Friedrich; Christian Hagel
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2014-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.